The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis-Reference-Cited by-同舟云学术

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis

Published:2016-09-08 Issue:1 Volume:3 Page:5-17
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Singh Vinayak¹,Donini Stefano²,Pacitto Angela³,Sala Claudia⁴,Hartkoorn Ruben C.⁴,Dhar Neeraj⁴,Keri Gyorgy⁵,Ascher David B.³,Mondésert Guillaume⁶,Vocat Anthony⁴,Lupien Andréanne⁴,Sommer Raphael⁴,Vermet Hélène⁶,Lagrange Sophie⁶,Buechler Joe⁷,Warner Digby F.¹,McKinney John D.⁴,Pato Janos⁵,Cole Stewart T.⁴,Blundell Tom L.³,Rizzi Menico²,Mizrahi Valerie¹

Affiliation:

1. MRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, Institute of Infectious Disease and Molecular Medicine & Department of Pathology, University of Cape Town, Anzio Road, Observatory 7925, South Africa

2. Dipartimento di Scienze del Farmaco, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy

3. Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom

4. Ecole Polytechnique Fédérale de Lausanne, Global Health Institute, Station 19, 1015 Lausanne, Switzerland

5. Vichem Chemie, Herman Ottó út 15, Budapest, 1022 Hungary

6. Sanofi-Aventis Research & Development, Infectious Diseases Unit, Biology Group, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280 Marcy L’Etoile, France

7. Alere (San Diego), Summer Ridge Road, San Diego, California 92121, United States

Funder

Howard Hughes Medical Institute

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

National Health and Medical Research Council

Bill and Melinda Gates Foundation

National Research Foundation

Seventh Framework Programme

South African Medical Research Council

Fondation Jacqueline Beytout

Swiss National Science Foundation

Publisher